Global Blood Therapeutics, Inc.: Wedbush Lowers Rating to Neutral







Marketzone with MT Newswires 2022

All the news about GLOBAL BLOOD THERAPEUTICS, INC.

Analyst Recommendations on GLOBAL BLOOD THERAPEUTICS, INC.

2022 turnover 280M
–
274M
2022 net result -301M
–
-295M
trso. net 2022 195M
–
191M
PER 2022-13.8x
2022 return–
Capitalization 4,156M
4,156M
4,067M
VE / CA 202214.2x
VE / CA 20239.10x
Number of employees457
Floating91.3%

Chart GLOBAL BLOOD THERAPEUTICS, INC.


Hard :

Period:




Global Blood Therapeutics, Inc.: Global Blood Therapeutics, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis GLOBAL BLOOD THERAPEUTICS, INC.

Short termMiddle termLong term
Trendsbullishbullishbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts18
Last Closing Price$63.84
Average price target$66.03
Deviation / Average Target3.43%

Officers and Directors




Source link -88